Octagon Capital Advisors LP Vincerx Pharma, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 1,000,000 shares of VINC stock, worth $810,000. This represents 0.79% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$810,000% of portfolio
0.79%Shares
1 transactions
Others Institutions Holding VINC
# of Institutions
39Shares Held
8.46MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$1.38 Million2.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct955KShares$773,4090.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$722,2920.12% of portfolio
-
Bank Of America Corp Charlotte, NC701KShares$568,1520.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA667KShares$540,2650.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $17.2M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...